<DOC>
	<DOCNO>NCT00587600</DOCNO>
	<brief_summary>This study do find Photodynamic Therapy ( treatment red light drug call photofrin ) Radiofrequency ablation work patient biomarkers ( abnormality molecules cell may may help predict cancer ) present Barrett 's esophagus patient biomarkers .</brief_summary>
	<brief_title>Biomarkers Phototherapy Barrett 's Esophagus</brief_title>
	<detailed_description />
	<mesh_term>Barrett Esophagus</mesh_term>
	<criteria>All patient biopsy proven Barrett 's esophagus evidence specialize intestinal epithelium dysplasia ( either high grade dysplasia low grade dysplasia ) histology . Patients must endoscopically visible segment Barrett 's esophagus great 1 centimeter length . All patient must eligible longterm followup well tolerate endoscopy , biopsy , cytology . Patients must willing travel Rochester , Minnesota followup Patients must friend relative accompany visit since sedative render unable operate motor vehicle If patient anticoagulation , must able tolerate reversal anticoagulation study biopsy therapy All patient must able tolerate proton pump inhibitor therapy . Esomeprazole provide change another proton pump inhibitor patient intolerant . All patient histological cytological evidence high grade dysplasia see experienced thoracic surgeon consideration esophagectomy . Patients unable follow light avoidance instruction Patients history prior esophageal surgery successful fundoplication Patients prior photodynamic therapy Patients preexist stricture esophagus Patients know allergy porphyrin compound Patients prior biopsy Barrett 's esophagus contain carcinoma Patients require continuous anticoagulation Patients pregnant capable pregnancy exclude study unless effective birth control measure Lactating mother exclude study unclear whether photosensitizer sodium porfimer cross feed infant Patients underlie liver disease exclude since metabolism porphyrin base photosensitizers uncertain . Evidence liver disease transaminase elevation three time normal , bilirubin increase twice normal , alkaline phosphatase ( liver fraction ) elevation twice normal . Patients underlie medical condition felt limit survival less one year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Barrett 's Esophagus</keyword>
	<keyword>High Grade Dysplasia</keyword>
	<keyword>Photodynamic Therapy</keyword>
</DOC>